bibliographic entry 6949501 [be/6949501]
https://w3id.org/oc/corpus/be/6949501

is a

• bibliographic reference

content

• AstraZeneca. Bristol-Myers Squibb. 52-week add-on to metformin comparison of saxagliptin and sulphonylurea, with a 52-week extension period. National Library of Medicine (US), 2000. https://clinicaltrials.gov/show/NCT00575588.

references

• https://w3id.org/oc/corpus/br/5659505